GENEVA, May 21, 2013 /CNW/ -
Campaign launched during World Health Assembly, where world's health
ministers gather to address the large physical and economic costs of
Mental and neurological disorders (MNDs) affect 700 million people
annually and account for 30 percent of global non-communicable disease
'Do You Mind?' helps patients, family members, policymakers and others
to understand the role each can play to collectively address MNDs
Today the International Federation of Pharmaceutical Manufacturers and
Associations (IFPMA) launched the 'Do You Mind?' campaign to focus
attention and to prompt action on MNDs. The campaign launch takes place
at the start of the 66th World Health Assembly, where health ministers meet to consider a global
mental health action plan.
'Do You Mind?' leverages various profiles to help patients, physicians,
employers, policymakers, and the general public understand the role
each actor can play in collectively addressing MNDs. Also interactive
questioning is used to highlight the impact of MNDs across society,
reduce stigma, and dispel common myths.
The World Health Organization reports that 700 million cases of MNDs
occur annually and that MNDs account for 30 percent of the global
non-communicable disease (NCD) burden. MNDs include schizophrenia,
epilepsy, Alzheimer's disease, and depression, which alone affects more
than 350 million people. In addition to the personal toll, MNDs have a
large socio-economic cost: 40 percent of lost worker productivity in
OECD countries is attributable to MNDs.
"More than just a health issue, MNDs should be a societal priority
involving decision makers from education, employment, science,
government and other spheres," said Eduardo Pisani, IFPMA Director
General. "'Do You Mind?' brings these actors together by showing how
everybody can act to collectively reduce suffering."
The campaign is publicly available and can be accessed at: http://www.DoYouMindCampaign.org
About the IFPMA:
IFPMA represents the research-based pharmaceutical companies and
associations across the globe. The research-based pharmaceutical
industry's 1.3 million employees research, develop and provide
medicines and vaccines that improve the life of patients worldwide.
Based in Geneva, IFPMA has official relations with the United Nations
and contributes industry expertise to help the global health community
find solutions that improve global health.
1. 'Sick on the Job? Myths and Realities about Mental Health and Work.'
For further information:
Peter Shelby, IFPMA, Tel: +41/22-338-3223, Mob: +41/79-820-2599, firstname.lastname@example.org; Ali Karami-Ruiz, IFPMA, Tel: +41/22-338-3229, Mob: +41/78-850-2903, email@example.com.